跳至主要内容
临床试验/NCT07059052
NCT07059052已完成不适用

Impact of Illness Perception on Quality of Life in Patients With Colorectal Cancer and Ascites

Hebei Provincial Hospital of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 218 人开始时间: 2024年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
218
试验地点
1
主要终点
Quality of Life Score

研究概览

简要总结

This study aimed to investigate the impact of illness perception on the quality of life (QoL) in patients diagnosed with colorectal cancer (CRC) complicated by ascites. The study explores how patients' cognitive and emotional beliefs about their illness relate to their physical, psychological, and social well-being.

详细描述

Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, and many patients are diagnosed at advanced stages with complications such as malignant ascites, which severely impairs quality of life (QoL). Illness perception, the framework of beliefs a patient develops about their illness, is known to influence health outcomes. However, this relationship is not well-studied in the specific subgroup of CRC patients with ascites.

This cross-sectional, observational study was designed to fill this gap. A total of 218 patients with CRC and ascites were enrolled. The study collected clinical and demographic data, and assessed illness perception using the Brief Illness Perception Questionnaire (BIPQ) and QoL using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). The primary goal was to analyze the correlation between dimensions of illness perception and domains of QoL, and to identify independent clinical and demographic factors that predict patient QoL. The findings are intended to inform the development of targeted psychosocial interventions to improve patient well-being in this vulnerable population.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of colorectal cancer with ascites, verified by imaging and pathological examination.
  • Patient and/or legal guardian provided informed consent.
  • Karnofsky Performance Status (KPS) score ≥
  • Estimated survival ≥6 months.

排除标准

  • Presence of other active malignant tumors.
  • Severe physical disability precluding participation.
  • Severe cardiac, hepatic, or renal dysfunction not related to CRC.
  • Presence of severe psychiatric or cognitive disorders.
  • History of alcohol or drug addiction.

结局指标

主要结局

Quality of Life Score

时间窗: Assessed once per participant during the study period from January 2024 to April 2025

Assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30, version 3.0). This 30-item questionnaire evaluates global health status, five functional scales (physical, role, emotional, cognitive, social), and symptom scales. All scores are transformed to a 0-100 scale. For functional scales and global QoL, higher scores represent better functioning or QoL.

Illness Perception Score

时间窗: Assessed once per participant during the study period from January 2024 to April 2025

Assessed using the Brief Illness Perception Questionnaire (BIPQ). This 8-item questionnaire evaluates cognitive and emotional representations of illness on a 0-10 scale. The total score ranges from 0 to 80, with higher scores indicating a more threatening or negative illness perception after reverse-scoring relevant items.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Xujin Guo

Principal Investigator

Hebei Provincial Hospital of Traditional Chinese Medicine

研究点 (1)

Loading locations...

相似试验